Atelectasis Formation: Role of Positive Pressure Breathing, Hyperoxia, &

Status Recruiting

Clinical Trial Summary

The primary aim of this project is to get further knowledge of the physiology of flight atelectasis and its prevention. We seek to: 1) assess whether low levels of positive pressure breathing can prevent atelectasis formation in humans during exposure to hyperoxia and +Gz-accelerations. 2) get further knowledge on the effects of hypobaria on regional ventilation and perfusion.

A secondary aim is to evaluate the effect of anti G-trouser inflation on ventilation and regional perfusion.

Clinical Trial Description

The effect of positive pressure breathing on lung function is being studied, when applied during exposure to hyperoxia and +Gz-accelerations. Focus is on lung tissue compression, ventilation and regional perfusion. In addition, the influence of hypobaria on these parameters is assessed.

This study is conducted in accordance with the amended Declaration of Helsinki. The Ethics Committee Ile-de-France III (ref. 3274) and the French National Agency for Drug Safety ANSM have approved the protocol (ref. ID RCB 2015-A00485-44 and ANSM 151046B-32).

Primary aim, item 1: Experiments are conducted in a human centrifuge. The protocol mimics a routine peacetime flight in combat aircraft, and includes 1hr05 min at +1Gz followed by 10-min exposure to +1.4 to +3.5Gz . Subjects are exposed three times to this sequence, breathing at positive pressure levels of 0, 5 or 10 hPa. Two groups of sixteen healthy male non-smoking volunteers, wearing anti-G trousers, are studied and compared: group 1 breathes air, group 2 100% O2.

Primary aim, item 2: Experiments are conducted in a hypobaric chamber. Sixteen healthy male non-smoking volunteers are exposed to four conditions: 0 or 15,000 ft altitude, breathing air or 100%O2. Protocol duration is 1h15min. Positive breathing pressure can be applied depending on the results of the experiments of item 1.

Secondary aim: Experiments are conducted in a human centrifuge. Sixteen healthy male non-smoking volunteers are exposed to four conditions: uninflated or inflated anti-G trousers (175 hPa), +1 or +3.5 Gz for 3 min. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03311347
Study type	Interventional
Source	Direction Centrale du Service de Santé des Armées
Contact	Stephanie S Montmerle-Borgdorff, MD, PhD
Phone	+33(1)78651249
Email	stephanie.montmerle@intradef.gouv.fr
Status	Recruiting
Phase	N/A
Start date	September 14, 2015
Completion date	January 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02870842` - Fraction of Inspired Oxygen and Atelectasis in Children	N/A
Withdrawn	`NCT02952066` - Expressions of TRPV1 in Airway of Asthmatics	N/A
Completed	`NCT04116567` - Lung Ultrasonography After Laparoscopic Gynecologic Surgery
Completed	`NCT02584023` - Lung Ultrasound and Alveolar Recruitment in Mechanically Ventilated Infants	N/A
Recruiting	`NCT06205212` - High-flow Nasal Oxygenation During Preoxygenation and Atelectasis	N/A
Completed	`NCT04566419` - poStoperative Anesthesia Care: Facial Mask vs Hfnc and Thoracic Ultrasound for Reduction of Atelectasis Incidence	N/A
Completed	`NCT04993001` - Impact of an Open Lung Extubation Strategy on Postoperative Pulmonary Complications	N/A
Completed	`NCT03630484` - Ventilator Hyperinflation and Manual Rib Cage Compression	N/A
Completed	`NCT02262182` - Interest of Positive Expiratory Pressure (PEP) Delivery by EzPAP® After Cardiac Surgery in the Management of Postoperative Atelectasis	N/A
Completed	`NCT01476254` - Respiratory Complications After Laparoscopic Surgery	N/A
Withdrawn	`NCT04566172` - Preoperative Optimization to Improve Functional Status	N/A
Completed	`NCT03763461` - HFNC During Awake Craniotomy - Impact on Patient Comfort	N/A
Recruiting	`NCT06430229` - Atelectasis Frequency in Different Ventilation Modes	N/A
Recruiting	`NCT06181279` - Effects of Individualized PEEP Guided by Driving Pressure on Postoperative Atelectasis in Patients With Morbid Obesity	N/A
Enrolling by invitation	`NCT05434624` - QT Distance and P Dispersion in ECG in Patients Having Bronchoscopy in the ICU	N/A
Withdrawn	`NCT02070445` - Ventilation During Cardiopulmonary Bypass (CPB) for Cardiac Surgery
Recruiting	`NCT02431455` - The Effect of Postoperative Incentive Spirometry on Pulmonary Function and Pulmonary Complications in Bariatric Surgery	N/A
Completed	`NCT03686631` - The Digital Incentive Spirometer (DIS): Improving Adherence to Incentive Spirometry	N/A
Active, not recruiting	`NCT03009331` - Descriptive and Comparative Study of Respiratory Function in the Postoperative Cardiac Surgery Patient	N/A
Recruiting	`NCT01289691` - Atelectasis After Pulmonary Lobectomy: The Effect Of Air During One-Lung Ventilation (OLV) On Postoperative Atelectasis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Atelectasis Formation: Role of Positive Pressure Breathing, Hyperoxia, and Hypobaria

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms